Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a solution for site-specific conjugation of proteins; Click Car for Split-CARs universal connectors; VACC-ZERA, a tool to generate recombinant proteins in microparticles; and CLICK'N CUT for tag-less protein purification. The company is based in Cádiz, Spain.…
Biotechnology Assets, S.A. (BST.MC) Gráfico de rendimientos estacionales
Biotechnology Assets (BME: BST) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 21 employees.
The shares were at 0.2030 EUR on 20 November 2026, down 34.7% over 52 weeks. Its 52-week range is 0.1760 EUR to 0.3200 EUR: the price is 36.6% below the high and 15.3% above the low.
Its market capitalisation is 15.45M EUR.
Biotechnology Assets reports return on equity of -27.5%, an operating margin of -37.1% and revenue down 10.8% year over year.
Its debt exceeds its cash by 633.92K EUR, a debt-to-equity ratio of 0.58. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.
No upcoming events tracked.